Skip to main content
. 2016 Feb 4;13(3):2476–2484. doi: 10.3892/mmr.2016.4868

Figure 3.

Figure 3

Effects of oxaliplatin and PT-100 combination therapy on the accumulation of CAFs in CT26 colon cancer cell-derived murine xenograft tumors. (A) Tumor growth curves. Values are expressed as the mean ± standard error of the mean. *P<0.05 vs. the three treatment groups. (B) Survival curves. (C) Hematoxylin and eosin staining of tumors harvested on day 22 (magnification, ×100). (D) Immunostaining for FAP, which is specifically expressed in CAFs, in tumors harvested on day 22 (magnification, ×200). (E) Detection of apoptotic cells in tumors excised on day 22 using the Deadend™ fluorometric terminal deoxynucleotidyl transferase dUTP nick end labeling system. (F) Western blot of FAP in the lysates of tumors excised on day 22. (G) Effects of oxaliplatin and PT-100 combination therapy on the expression of cytokines associated with CAFs in CT26 colon cancer cell-derived murine xenograft tumors. Tumors were resected at day 22 and the cytokine expression levels were assessed using reverse-transcription quantitative polymerase chain reaction analysis. *P<0.05 vs. the saline vehicle control. Values are expressed as the mean ± standard error of the mean. CAF, cancer-associated fibroblast; FAP, fibroblast activation protein.